secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001370053-26-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio reports preliminary cash & investments of ~$310M as of Dec 31, 2025
------------------------------------------------------------------------------

- Preliminary unaudited cash, equivalents and investments ~$310M as of Dec 31, 2025.
- Audited FY2025 financials not yet available; final results may differ materially.
- Disclosure to be made at J.P. Morgan Healthcare Conference on January 11, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/0001370053-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/anab-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001370053-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer